Choksi Laboratories Submits Q4FY26 Compliance Certificate Under SEBI Regulation 74(5)
Choksi Laboratories Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) to BSE Limited on 07-04-2026. The certificate, issued by registrar MUFG Intime India Private Limited, confirms proper handling of securities dematerialisation processes during the quarter ended 31st March 2026. The submission demonstrates the company's adherence to regulatory requirements for depository participant processes and securities handling.

*this image is generated using AI for illustrative purposes only.
Choksi laboratories Limited has submitted its compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 31st March 2026. The pharmaceutical company filed the mandatory certificate with BSE Limited on 07-04-2026, ensuring adherence to regulatory requirements for securities dematerialisation processes.
Regulatory Compliance Details
The compliance certificate was issued by MUFG Intime India Private Limited (formerly Link Intime India Private Limited), which serves as the company's registrar and share transfer agent. The certificate confirms that all securities received from depository participants for dematerialisation during Q4FY26 were properly processed within prescribed timelines.
| Parameter: | Details |
|---|---|
| Quarter Covered: | Q4FY26 (ended 31st March 2026) |
| Filing Date: | 07-04-2026 |
| Registrar: | MUFG Intime India Private Limited |
| Certificate Date: | April 3, 2026 |
| Script Code: | 526546 |
Certificate Confirmation
MUFG Intime India confirmed that securities received from depository participants during the quarter were appropriately accepted or rejected to the depositories. The registrar verified that all security certificates received for dematerialisation were properly mutilated and cancelled after due verification by depository participants.
Key confirmations included in the certificate:
- Securities were confirmed to depositories within prescribed timelines
- Security certificates comprised in dematerialisation were listed on relevant stock exchanges
- Names of depositories were substituted in the register of members as registered owners
- All processes followed regulatory guidelines for dematerialisation
Corporate Information
Choksi Laboratories Limited operates from its corporate office and central laboratory located at Survey No 9/1, Near Tulsiyana Industrial Park, Gram Kumerdi, Indore. The company secretary and compliance officer Prakhar Dubey signed the submission to BSE Limited, ensuring proper documentation of the regulatory compliance.
The submission reflects the company's commitment to maintaining transparency and adhering to SEBI regulations governing depositories and participants. This quarterly compliance certificate is a mandatory requirement under SEBI regulations to ensure proper handling of securities dematerialisation processes.
Historical Stock Returns for Choksi Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.21% | -5.41% | +2.03% | -46.75% | -13.27% | +1,211.91% |
How might the transition from Link Intime to MUFG Intime India impact Choksi Laboratories' future share transfer operations and costs?
What potential business developments could Choksi Laboratories announce in their upcoming Q4FY26 earnings report following this compliance filing?
Will SEBI introduce any new regulatory changes for depositories that could affect pharmaceutical companies' compliance requirements in FY27?






























